Can a commercial gel dosimetry system be used to verify stereotactic spinal radiotherapy treatment dose distributions? by Kairn, Tanya et al.
This content has been downloaded from IOPscience. Please scroll down to see the full text.
Download details:
IP Address: 131.181.30.123
This content was downloaded on 08/06/2017 at 01:51
Please note that terms and conditions apply.
Can a commercial gel dosimetry system be used to verify stereotactic spinal radiotherapy
treatment dose distributions?
View the table of contents for this issue, or go to the journal homepage for more
2017 J. Phys.: Conf. Ser. 847 012071
(http://iopscience.iop.org/1742-6596/847/1/012071)
Home Search Collections Journals About Contact us My IOPscience
You may also be interested in:
Monte Carlo verification of gel dosimetry measurements for stereotactic radiotherapy
T Kairn, M L Taylor, S B Crowe et al.
Verification of dose volume histograms in stereotactic radiosurgery and radiotherapy using polymer
gel and MRI
Jitka Šemnická, Josef Novotný Jr, Václav Spváek et al.
Stereotactic body radiation therapy delivery validation
T Olding, L Garcia, K Alexander et al.
Deformable gel dosimetry I: application to external beam radiotherapy and brachytherapy
U J Yeo, M L Taylor, J R Supple et al.
Comparison between polymer gel dosimetry and calculated dose with small field in stereotactic
irradiation
H Kawamura, K Shinoda, H Fuse et al.
NMR mechanisms in gel dosimetry
L J Schreiner
Sequential beam integration characteristics of a methacrylic acid based normoxic polymer gel
dosimeter
Anna Karlsson, Helen Gustavsson, Sofie Månsson et al.
Delivery validation of VMAT stereotactic ablative body radiotherapy at commissioning
T Olding, K M Alexander, C Jechel et al.
1Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution
of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
Published under licence by IOP Publishing Ltd
1234567890
9th International Conference on 3D Radiation Dosimetry   IOP Publishing
IOP Conf. Series: Journal of Physics: Conf. Series 847 (2017) 012071  doi :10.1088/1742-6596/847/1/012071
 
 
 
 
 
 
Can a commercial gel dosimetry system be used to verify 
stereotactic spinal radiotherapy treatment dose distributions?  
T Kairn, 2, A Asena2, S B Crowe2,3, A Livingstone3, D Papworth1, S Smith2, B 
Sutherland1, S Sylvander3, R D Franich4 and J V Trapp2 
1Genesis Cancer Care Queensland, Brisbane, Australia 
2School of Chemistry, Physics, and Mechanical Engineering, Queensland University of 
Technology, Brisbane, Australia 
3Royal Brisbane and Women’s Hospital, Brisbane, Australia 
4School of Science, RMIT University, Melbourne, Australia 
 
E-mail: t.kairn@gmail.com 
 
Abstract. This study investigated the use of the TruView xylenol-orange-based gel and VISTA 
optical CT scanner (both by Modus Medical Inc, London, Canada), for use in verifying the 
accuracy of planned dose distributions for hypo-fractionated (stereotactic) vertebral treatments. 
Gel measurements were carried out using three stereotactic vertebral treatments and compared 
with planned doses calculated using the Eclipse treatment planning system (Varian Medical 
Systems, Palo Alto, USA) as well as with film measurements made using Gafchromic EBT3 
film (Ashland Inc, Covington, USA), to investigate the accuracy of the gel system. The gel was 
calibrated with reference to a moderate-dose gradient region in one of the gel samples. Generally, 
the gel measurements were able to approximate the close agreement between the doses calculated 
by the treatment planning system and the doses measured using film (which agreed with each 
other within 2%), despite lower resolution and bit depth. Poorer agreement was observed when 
the dose delivered to the gel exceeded the range of doses delivered in the calibration region. This 
commercial gel dosimetry system may be used to verify hypo-fractionated treatments of 
vertebral targets, although separate gel calibration measurements are recommended. 
1. Introduction 
Radiotherapy treatments of vertebral targets are challenging to plan and deliver, due to the geometry of 
the anatomy involved. It is especially important to verify the dose falloff between the targeted vertebra 
and adjacent spinal cord, and to establish that the spinal cord is adequately spared, for hypo-fractionated 
(stereotactic) treatments where elevated radiation doses are delivered over few fractions [1]. While 
valuable dose gradient information can be derived from two-dimensional film measurements in the 
coronal and sagittal planes [2, 3], the three-dimensional measurement capability of dosimetry gels gives 
them the potential to provide information about the consistency of the dose gradient, along the whole 
treatment volume, as well as a more comprehensive indication of the accuracy and deliverability of the 
planned dose. 
      This study investigated the use of a commercial gel dosimetry [4] system, for use in verifying 
the accuracy of planned dose distributions for vertebral treatments. Gel measurements were carried out 
and compared with planned doses and film measurements, to investigate the accuracy of the gel system 
and evaluate the suitability of a simple calibration method. In addition to providing an evaluation of a 
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specific gel dosimetry system, this study also provides a useful method for registering planned and 
measured 3D dose distributions, as well as an overall technique for evaluating commercial (or novel) 
gel dosimetry systems.  
 
2. Method 
Three different stereotactic ablative body radiotherapy (SABR) treatments were planned for vertebral 
targets, for delivery using a volumetric modulated arc therapy (VMAT) technique, using a Varian 
Truebeam linac with Millennium MLC (Varian Medical Systems, Palo Alto, USA). In all three cases, 
the prescribed dose to the planning target volume (PTV) was 24 Gy in 3 fractions and the maximum 
dose to the spinal cord was required to be below 17.5 Gy. Each of these treatment plans was copied onto 
a CT scan of a 20×20×10 cm3 water-equivalent plastic phantom, for comparison with a two-dimensional 
dose measurement made using EBT3 radiochromic film (Ashland Inc, Covington, USA), and also 
copied onto CT scans of three cylinders of TruView gel (Modus Medical Inc, London, Canada) for 
comparison with a three-dimensional gel dosimetry measurement.   
      The gel measurements were made using three standard 800 ml cylinders (9.6 cm diameter, 11 cm 
height) of ferrous-xylenol orange based TruView gel. All three samples were individually CT scanned, 
with radio-opaque markers used to indicate the scanning and irradiation setup position and aid in the 
registration of the 3D scanned image from the irradiated gel with the 3D dose distribution from the 
treatment planning system.  
      Gel handling and irradiations followed the recommendations provided by the manufacturer [5]. 
Gel results were read out using optical CT, using the VISTA optical CT scanner (Modus Medical Inc, 
London, Canada) [6]. During scanning the gel was immersed in a refractive index matching fluid made 
from mixing glycerol, water and food colouring, as recommended by the manufacturer [7].  
      Pre-irradiation optical CT scans of all three gel samples were acquired, with radio-opaque markers 
in situ. Additional radio-opaque markers were added to the gel containers after irradiation, so that marker 
positions would remain visible even after the post-irradiation optical CT scans of the gel were 
background-corrected [8] via the subtraction of the pre-irradiation scan data.  
      For irradiation using the three different vertebral SABR treatment plans, the gel samples were 
positioned with their longer dimension parallel to the linac couch’s longitudinal (craniocaudal) direction. 
The set up and delivery of each irradiation took less than four minutes. Optical CT scanning was 
completed 60 minutes after irradiation.  
      The film measurements were made with the film in the centre of the solid water, oriented in the 
transverse plane, and with one fraction from each of the test treatments delivered to each of three sheets 
of film. The handing, scanning and calibration of the EBT3 film was completed as previously described 
[9-11], with scans obtained before and after irradiation and results analysed using the red channel only.  
 
3. Results 
Figure 1 shows the quadratic calibration curve that was used to convert pixel values from all scans of 
the TruView gels into measured dose. This measurement result provides a strong indication that the 
dose-response of the TruView gel and VISTA readout system was non-linear. The dotted line shown in 
Figure 1 provides an indication of the degree to which the doses to out-of-field regions would be over-
estimated if a linear dose-response was assumed (as is suggested by the manufacturer [5]) and combined 
with a renormalisation using the maximum dose (as is frequently applied in when gel dosimetry 
measurements are compared to clinical treatment plans [12]). 
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Figure 1. Calibration relationships (solid and dotted lines) 
derived from measurement data (diamonds) produced by 
irradiating a sample of TruView gel using one of the SABR 
test treatment plans and then assuming agreement between the 
planned and measured doses in a moderate-dose-gradient 
region (see Figure 2(a)). The solid line shows a quadratic fit to 
all data points. The dotted line shows a linear fit to the high-
dose values only. 
 
      Figures 2(a)-(f) and 3(a)-(f) show profiles though the planned and measured doses from the three 
different spine SABR treatment plans. In all cases, the results of the film measurements agree closely 
with the planned treatment doses (mostly within 2%). The film measurement therefore confirms the 
accuracy of the treatment planning system’s dose calculation, so that the planned dose distribution can 
be used as the “ground truth” against which the gel measurement can be verified. Compared to the film 
results, the gel profiles show the effects of increased noise, decreased scanning resolution and decreased 
pixel bit depth.  
      The gel measurement shown in Figure 2(a) was used to derive the calibration data that was used 
to convert pixel values from all the gel measurements into dose (shown in Figure 1) and therefore shows 
the closest agreement with the planned dose. Of the other two gel measurements, the closest agreement 
with the treatment plan (and therefore with the film measurement) was achieved in the plan that was 
most dosimetrically similar to the plan used for the calibration (Figures 2(b) and 3(b)), while the poorest 
agreement was observed in the plan involving doses that substantially exceeded the maximum 
calibration dose (Figures 2(c) and 3(c)).  
      It is possible that the level of agreement between the gel measurements and the planned doses 
shown in Figures 2(a)-(f) and 3(a)-(f) may have been over-estimated, due to the calibration method 
chosen for use in this study. This calibration method lacks the independence of a separate calibration, 
and produces measurement results which are, by definition, unable to identify any inaccuracies in the 
dose measurement within the calibration region. Given the apparent non-linear dose response produced 
in the TruView gel by the hypo-fractionated treatments investigated in this study, it may be advisable to 
perform an independent calibration measurement (using small vials of gel irradiated to different doses 
or using a single gel sample irradiated using a known dose profile such as a percentage depth-dose or a 
wedged profile) whenever TruView gels are used to examine high-dose (stereotactic) treatments. (Note 
that the film was independently calibrated using reference films irradiated up to 3000 cGy.) 
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Figure 2. Anterior-posterior dose profiles through the planned target region, showing comparisons between the 
planned and measured doses in the gel samples (panels (a), (b) and (c)) and comparisons between the planned and 
measured doses in the film (panels (d), (e) and (f)), for the three different spine SABR treatments. The calibration 
region (where the dose measured in the gel was assumed equal to the planned dose) is highlighted in panel (a). 
 
Figure 3. Lateral dose profiles through the planned spinal cord avoidance region, showing comparisons 
between the planned and measured doses in the gel samples (panels (a), (b) and (c)) and comparisons between 
the planned and measured doses in the film (panels (d), (e) and (f)), for the three different spine SABR 
treatments. 
 
4. Conclusion 
The results of this study suggest that for the relatively small target volumes involved in stereotactic 
spinal radiotherapy, TruView gel and VISTA optical CT scanner are able to approximate the doses 
measured using film, despite lower resolution and bit depth. Poorer agreement is observed when the 
dose delivered to the gel exceeds the range of doses used in the calibration. This commercial gel 
dosimetry system may be used to verify hypo-fractionated treatments of vertebral targets, although 
separate gel calibration measurements are recommended.  
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      All doses reported in this study were calculated and measured within media with homogeneous 
densities. Routine quality assurance of vertebral SABR treatment plans should not use homogeneous 
media unless the treatment planning system has been thoroughly commissioned and shown to calculate 
dose accurately when highly modulated, high-dose treatments are planned for bony anatomy.  
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